Bengaluru: Medi Assist reported a 13 per cent year on year rise in operating revenue to Rs 478 crore in H1 2027.
Operating ebitda increased 19 per cent to Rs 97.2 crore as ebitda margins expanded 103 bps to 20.3 per cent.
Total premiums under management across platform and TPA operations reached Rs 24,752 crore. Profit Before Tax (PBT) grew 47.0 per cent YoY, and Profit After Tax (PAT) rose 60.2 per cent YoY.
Group health benefits market share reached 34.1 per cent (+182 bps YoY), with 90.5 per cent client retention.
Group premiums under management grew 21.8 per cent YoY to Rs 13,939 Cr in H1 FY27, outpacing industry growth by 650 bps, the company added.
In terms of Technology Monetisation, the company’s SaaS and licensing revenue grew 112.6 per cent in Q2 FY27 and 83.8 per cent YoY to Rs 18.1 Cr in H1 FY27.
Three of seven contracted insurers are fully live on the stack, with the remaining four scheduled to go live in H2 FY27.
Claim-based fees are scaling with volume, supported by Rs 9,648 Cr in platform premiums in H1 FY27.
Medi Assist added that it delivered 13.7% group revenue growth in H1 FY27 and that it remains debt-free, with Rs 268.3 crore in cash and cash equivalents to support strategic investment and financial resilience.
Satish Gidugu, CEO & Whole Time Director said, “Medi Assist is advancing access, accountability and affordability in healthcare. Insurer adoption of our technology, key government mandates and Mayfair’s international expansion reinforce our growth momentum and commitment to reliable, transparent service.
With Paramount fully integrated, our core platform generates strong cash flows to fund growth. The Board-approved buyback reflects disciplined capital allocation and confidence in long-term earnings, while preserving liquidity for investment.”
Join the community of 2M+ industry professionals.
Subscribe to Newsletter to get latest insights & analysis in your inbox.
All about ETHealthworld industry right on your smartphone!
- Download the ETHealthworld App and get the Realtime updates and Save your favourite articles.
